The Food and Drug Administration is giving the University of Alabama at Birmingham the green light to study the use of a marijuana derivative to treat seizures. Parents of children with seizure disorders persuaded the Alabama Legislature last year to pass a bill authorizing UAB's Department of Neurology to do a study of the marijuana derivative cannabidiol as a seizure treatment. A UAB spokesman said Tuesday that the FDA has approved the study, but has requested modifications. A university review board will discuss the changes next month.
The Food and Drug Administration has given the first OK for a drug to prevent HIV infection.
The daily pill Truvada, made by Gilead Sciences, combines two medicines that inhibit the reproduction of HIV. It's been a mainstay in the treatment of HIV/AIDS for years, and as of today is an approved option for reducing the risk of HIV infection for people at high risk.